Dongyang Pharmaceutical (06887.HK): Glucose-insulin injection has received approval for listing from the US Food and Drug Administration.

Zhitong Finance and Economics APP News, Dong Yang Guangyao (06887.HK) announced that the self-developed Ganjing Insulin Injection of this group has obtained the approval letter issued by the Food and Drug Administration (FDA) of the United States.